- Home
- Automated
- List of product information
- FLUIMUCIL GRANULES 100 MG/SACHET [SIN03414P]
FLUIMUCIL GRANULES 100 MG/SACHET [SIN03414P]
Active ingredients: FLUIMUCIL GRANULES 100 MG/SACHET
Product Info
FLUIMUCIL GRANULES 100 MG/SACHET
[SIN03414P]
Product information
Active Ingredient and Strength | ACETYLCYSTEINE - 100 MG/SACHET |
Dosage Form | GRANULE |
Manufacturer and Country | ZAMBON SWITZERLAND LTD - SWITZERLAND |
Registration Number | SIN03414P |
Licence Holder | UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED |
Forensic Classification | PHARMACY ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | R05CB01 |
INDICATIONS
FLUIMUCIL® is indicated as an adjuvant treatment in certain clinical condition characterized by the presence of thick and viscous mucoid or mucopurulent secretions such as:
Chronic bronchopulmonary diseases (chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis);
Acute bronchopulmonary diseases (asthma with bronchial mucus plugging, bronchitis, bronchopneumonia, tracheobronchitis, bronchiolitis, pulmonary complications of cystic fibrosis, pulmonary complications associated with surgery).
POSOLOGY
Adults and children above 6 years
1 sachet FLUIMUCIL® 200mg or 2 sachets FLUIMUCIL® 100mg, 2–3 times a day;
Children (2–6 years of age)
1 sachet FLUIMUCIL® 100 mg from 2 to 4 times a day, according to the age.
The duration of treatment should be 5 to 10 days in the acute treatment, whereas it may be continued in the chronic states for several months, according to the advice of the physician.
MODALITY OF USE
Dissolve the contents of the sachets in a glass containing a small quantity of water, mixing it, if necessary, with a spoon. A palatable solution is thus obtained, to be drunk immediately.
CONTRAINDICATIONS
Known hypersensitivity to acetylcysteine or to any of the excipients (please see below the section Warning and Precautions – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information)
Children under 2 years of age.
